Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

AXSM Axsome Therapeutics Inc

83,9962

0,2162 (0,26%)

Zuletzt aktualisiert: 16:09:01

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Axsome Therapeutics (NASDAQ:AXSM)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Axsome Therapeutics Charts.

Axsome Therapeutics (NASDAQ:AXSM)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Axsome Therapeutics Charts.

News Axsome Therapeutics Inc

Form 4 - Statement of changes in beneficial ownership of securities
Montag 6 Januar 2025 (2 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 30 Dezember 2024 (1 Woche vor) • Edgar (US Regulatory)

Axsome Therapeutics Announces Successful Completion and Results of Phase 3 Clinical Program of AXS-05 in Alzheimer’s Disease Agitation
Montag 30 Dezember 2024 (1 Woche vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 26 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in ENCORE Long-Term Phase 3 Trial in Narcolepsy
Dienstag 26 November 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 20 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 12 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Axsome Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Dienstag 12 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Axsome Therapeutics Presents Data from Its Leading Neuroscience Pipeline at NEI Congress 2024
Freitag 8 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Axsome Therapeutics Presents Data from Multiple Programs Spanning Its Innovative Neuroscience Portfolio at Psych Congress 2024
Dienstag 29 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 3 - Initial statement of beneficial ownership of securities
Freitag 25 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12
Dienstag 15 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Axsome Therapeutics Inc News-Artikel

Euro vs US Dollar

Invesco QQQ Trust Series 1

Health Care Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen